Optiver Holding
ABVX

Optiver Holding’s Abivax ABVX Stock Holding History

Optiver Holding’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$505K Buy
4,538
+4,120
+986% +$488K ﹤0.01% 650
2025
Q4 		$56.4K Sell
418
-22,686
-98% -$2.48M ﹤0.01% 882
2025
Q3 		$1.96M Buy
+23,104
New +$1.42M ﹤0.01% 398

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Optiver Holding's ABVX Position: Q1 2026 in Review

Optiver Holding increased its Abivax (ABVX) stake by 986% in Q1 2026, buying an estimated $488K and bringing the position to 4,538 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Optiver Holding first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.96M in Q3 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Optiver Holding held 4,538 shares of Abivax worth $505K as of Q1 2026.
  • Optiver Holding bought 4,120 Abivax shares in Q1 2026, an estimated $488K.
  • Abivax made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #650 holding.
  • Optiver Holding first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Abivax position peaked at $1.96M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.